Large-scale Generation of Functional and Transplantable Hepatocytes and Cholangiocytes from Human Endoderm Stem Cells
Sisi Feng,Jiaying Wu,Wei-Lin Qiu,Li Yang,Xiaogang Deng,Ying Zhou,Yabin Chen,Xiao Li,Lei Yu,Hongsheng Li,Zi-Ran Xu,Yini Xiao,Xiongzhao Ren,Ludi Zhang,Chenhua Wang,Zhen Sun,Jinglin Wang,Xiaoyan Ding,Yuelei Chen,Paul Gadue,Guoyu Pan,Mina Ogawa,Shinichiro Ogawa,Jie Na,Peilin Zhang,Lijian Hui,Hao Yin,Luonan Chen,Cheng-Ran Xu,Xin Cheng
DOI: https://doi.org/10.1016/j.celrep.2020.108455
IF: 8.8
2020-12-01
Cell Reports
Abstract:The ever-increasing therapeutic and pharmaceutical demand for liver cells calls for systems that enable mass production of hepatic cells. Here we describe a large-scale suspension system that uses human endoderm stem cells (hEnSCs) as precursors to generate functional and transplantable hepatocytes (E-heps) or cholangiocytes (E-chos). hEnSC-derived hepatic populations are characterized by single-cell transcriptomic analyses and compared with hESC-derived counterparts, <em>in-vitro-</em>maintained or -expanded primary hepatocytes and adult cells, which reveals that hepatic differentiation of hEnSCs recapitulates <em>in vivo</em> development and that the heterogeneities of the resultant populations can be manipulated by regulating the EGF and MAPK signaling pathways. Functional assessments demonstrate that E-heps and E-chos possess properties comparable with adult counterparts and that, when transplanted intraperitoneally, encapsulated E-heps were able to rescue rats with acute liver failure. Our study lays the foundation for cell-based therapeutic agents and <em>in vitro</em> applications for liver diseases.
cell biology